AMZN
64
-2
ALL
50
5
PRU
54
-2
MAS
62
4
PNW
66
3
REGN
42
3
UA
57
-21
EW
27
2
NKE
30
2
ETN
84
2
NEM
42
10
DE
35
-13
IBM
53
2
R
75
3
MTCH
26
-7
SYK
64
2
OKE
80
2
KO
42
4
LEN
55
6
URI
72
3
AMZN
64
-2
ALL
50
5
PRU
54
-2
MAS
62
4
PNW
66
3
REGN
42
3
UA
57
-21
EW
27
2
NKE
30
2
ETN
84
2
NEM
42
10
DE
35
-13
IBM
53
2
R
75
3
MTCH
26
-7
SYK
64
2
OKE
80
2
KO
42
4
LEN
55
6
URI
72
3
Financhill
Back

Entrada Therapeutics Vs. Avidity Biosciences Industry Stock Comparison

Buy
79

TRDA
Entrada Therapeutics

Last Price:
19.91
Seasonality Move:
-35.78%
Sell
39

RNA
Avidity Biosciences

Last Price:
46.69
Seasonality Move:
33.04%
Buy
79
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $19.82. The Score for TRDA is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $46.71. The Score for RNA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $19.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $46.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.72 Buy
Relative Strength Index (14 RSI): 76.45 Buy
Chaikin Money Flow: 178906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.52 - 18.3) Buy
Bollinger Bands (100): (14.75 - 17.41) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 54.01 Buy
Chaikin Money Flow: 478392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.93 - 47.73) Buy
Bollinger Bands (100): (41.07 - 46.53) Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.26 Buy
20-day SMA: 17.66 Buy
50-day SMA: 16.4 Buy
200-day SMA: 15.02 Buy
8-day EMA: 18.54 Buy
20-day EMA: 17.73 Buy
50-day EMA: 16.85 Buy
200-day EMA: 15.58 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.84 Buy
20-day SMA: 45.91 Buy
50-day SMA: 44.53 Buy
200-day SMA: 33.31 Buy
8-day EMA: 45.81 Buy
20-day EMA: 45.52 Buy
50-day EMA: 44.7 Buy
200-day EMA: 34.96 Buy

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and a decrease next year of $4.05 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.40 per share.

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):